Koninklijke Philips NV
PHG25.020USD
-0.240-0.95%
Fechamento 04/29, 16:00（ET）Cotações atrasadas em 15 min
23.14BValor de mercado
PerdaP/L TTM
Mais detalhes de Koninklijke Philips NV Empresa
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Informações da empresa
Código da empresaPHG
Nome da EmpresaKoninklijke Philips NV
Data de listagemSep 18, 2009
Fundado em2000
CEOMr. Roy Jakobs
Número de funcionários67823
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
EndereçoHigh Tech Campus 5
CidadeEINDHOVEN
Bolsa de valoresThe Stock Exchange of Thailand
PaísNetherlands
Código postal5656 AE
Telefone31205977777
Sitehttps://www.philips.com/
Código da empresaPHG
Data de listagemSep 18, 2009
Fundado em2000
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. David E. I. Pyott, CBE
Mr. David E. I. Pyott, CBE
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--
Ms. Ozlem Duzen Fidanci
Ms. Ozlem Duzen Fidanci
Executive Vice President, Chief of International Region and Leader Growth Region
Executive Vice President, Chief of International Region and Leader Growth Region
--
--
Ms. Liu Ling
Ms. Liu Ling
Executive Vice President, Chief Region Leader of Philips Greater China
Executive Vice President, Chief Region Leader of Philips Greater China
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. David E. I. Pyott, CBE
Mr. David E. I. Pyott, CBE
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
7.82B
40.10%
Other Countries
6.05B
31.05%
Netherlands
2.71B
13.91%
China
1.25B
6.40%
Japan
958.28M
4.92%
Germany
706.27M
3.62%
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: sex, 28 de mar
Tempo de atualização: sex, 28 de mar
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Mondrian Investment Partners Ltd.
0.77%
Fiduciary Management, Inc.
0.67%
Fidelity Management & Research Company LLC
0.59%
Dimensional Fund Advisors, L.P.
0.46%
BlackRock Investment Management, LLC
0.26%
Other
97.25%
Estatísticas dos acionistas
Acionista
Proporção
Mondrian Investment Partners Ltd.
0.77%
Fiduciary Management, Inc.
0.67%
Fidelity Management & Research Company LLC
0.59%
Dimensional Fund Advisors, L.P.
0.46%
BlackRock Investment Management, LLC
0.26%
Other
97.25%
Tipo
Acionista
Proporção
Investment Advisor
4.33%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.28%
Hedge Fund
0.17%
Bank and Trust
0.07%
Family Office
0.05%
Family Office
0.04%
Family Office
0.04%
Other
93.56%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
559
59.05M
6.38%
-13.12M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
2023Q2
676
66.71M
7.01%
-36.31M
2023Q1
689
68.47M
7.19%
-38.94M
2022Q4
703
88.43M
9.29%
-24.60M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Mondrian Investment Partners Ltd.
7.14M
0.77%
-759.34K
-9.62%
Dec 31, 2024
Fiduciary Management, Inc.
6.18M
0.67%
-290.89K
-4.50%
Dec 31, 2024
Fidelity Management & Research Company LLC
5.48M
0.59%
-35.58K
-0.65%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
4.29M
0.46%
+85.99K
+2.05%
Dec 31, 2024
BlackRock Investment Management, LLC
2.38M
0.26%
-611.98K
-20.43%
Dec 31, 2024
Connor, Clark & Lunn Investment Management Ltd.
2.22M
0.24%
+1.04M
+87.71%
Dec 31, 2024
Parametric Portfolio Associates LLC
1.74M
0.19%
-71.06K
-3.91%
Dec 31, 2024
Causeway Capital Management LLC
1.57M
0.17%
+303.43K
+24.02%
Dec 31, 2024
Northern Trust Global Investments
1.36M
0.15%
+259.57K
+23.61%
Dec 31, 2024
Thompson, Siegel & Walmsley LLC
1.32M
0.14%
-355.67K
-21.18%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
Langar Global HealthTech ETF
5.58%
Brandes International ETF
1.64%
Brandes US Small-Mid Cap Value ETF
1.32%
ActivePassive International Equity ETF
0.34%
DFA Dimensional Intl Sustainability Core 1 ETF
0.2%
Avantis International Large Cap Value ETF
0.2%
Avantis Responsible International Equity ETF
0.15%
SPDR S&P Kensho New Economies Composite ETF
0.14%
Avantis International Equity ETF
0.11%
DFA Dimensional International Core Equity 2 ETF
0.1%
Ver Mais
Langar Global HealthTech ETF
Proporção5.58%
Brandes International ETF
Proporção1.64%
Brandes US Small-Mid Cap Value ETF
Proporção1.32%
ActivePassive International Equity ETF
Proporção0.34%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporção0.2%
Avantis International Large Cap Value ETF
Proporção0.2%
Avantis Responsible International Equity ETF
Proporção0.15%
SPDR S&P Kensho New Economies Composite ETF
Proporção0.14%
Avantis International Equity ETF
Proporção0.11%
DFA Dimensional International Core Equity 2 ETF
Proporção0.1%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados